| scholarly article | Q13442814 |
| P2093 | author name string | Yang Li | |
| Jie Liu | |||
| Yu Tian | |||
| Yan Zhao | |||
| Qingsong Li | |||
| Yongri Zheng | |||
| Fei Yuan | |||
| Shuguang Yang | |||
| Fenggang Zhou | |||
| Jianjiao Wang | |||
| Qiongyu Ji | |||
| P2860 | cites work | Current promising treatment strategy for glioblastoma multiform: A review | Q92605242 |
| A CDC20-APC/SOX2 Signaling Axis Regulates Human Glioblastoma Stem-like Cells | Q35782988 | ||
| CDC20 maintains tumor initiating cells | Q35955263 | ||
| Targeting long non-coding RNA to therapeutically upregulate gene expression | Q38110692 | ||
| Long non-coding RNAs in glioma: functional roles and clinical perspectives. | Q38216769 | ||
| The emerging role of lncRNAs in cancer | Q38626016 | ||
| Multiple high-grade gliomas: epidemiology, management, and outcome. A systematic review and meta-analysis. | Q47594798 | ||
| Cdc20 overexpression is involved in temozolomide-resistant glioma cells with epithelial-mesenchymal transition | Q47648800 | ||
| Gene expression profiling in glioblastoma and immunohistochemical evaluation of IGFBP-2 and CDC20. | Q48863501 | ||
| lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer. | Q52721285 | ||
| Novel approach to temozolomide resistance in malignant glioma: connexin43-directed therapeutics. | Q55456964 | ||
| Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma | Q57153312 | ||
| Long non-coding RNA EPIC1 promotes cholangiocarcinoma cell growth | Q57279341 | ||
| Systematic identification of non-coding pharmacogenomic landscape in cancer | Q58793778 | ||
| Temozolomide Induced Hypermutation in Glioma: Evolutionary Mechanisms and Therapeutic Opportunities | Q61800092 | ||
| Long non-coding RNA linc00645 promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-205-3p-ZEB1 axis in glioma | Q90317219 | ||
| Long non-coding RNA EPIC1 promotes human lung cancer cell growth | Q90371783 | ||
| lncRNA LINC01494 Promotes Proliferation, Migration And Invasion In Glioma Through miR-122-5p/CCNG1 Axis | Q90397992 | ||
| LncRNA RHPN1-AS1 Targeting miR-625/REG3A Promotes Cell Proliferation And Invasion Of Glioma Cells | Q90427414 | ||
| Novel management of glioma by molecular therapies, a review article | Q90448387 | ||
| Functional Roles of Long Non-Coding RNAs (LncRNAs) in Glioma Stem Cells | Q90589822 | ||
| Blocking lncRNA MALAT1/miR-199a/ZHX1 Axis Inhibits Glioblastoma Proliferation and Progression | Q90924165 | ||
| Cancer statistics, 2019 | Q90941571 | ||
| Targeting autophagy for combating chemoresistance and radioresistance in glioblastoma | Q91255027 | ||
| Long non-coding RNA EPIC1 inhibits viability and invasion of osteosarcoma cells by promoting MEF2D ubiquitylation | Q91291454 | ||
| Cellular functions of long noncoding RNAs | Q91713084 | ||
| miR‑342 inhibits glioma cell proliferation by targeting GPRC5A | Q92208491 | ||
| Non-coding RNAs: Regulators of glioma cell epithelial-mesenchymal transformation | Q92459057 | ||
| P921 | main subject | drug resistance | Q12147416 |
| P304 | page(s) | 130-137 | |
| P577 | publication date | 2020-03-30 | |
| P1433 | published in | Molecular therapy oncolytics | Q27726823 |
| P1476 | title | Long Non-coding RNA EPIC1 Promotes Cell Proliferation and Motility and Drug Resistance in Glioma | |
| P478 | volume | 17 |
Search more.